EUROAPI
Paris, France
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (9)
○ EMA GMP
○ MHRA GMP
Quick Facts: EUROAPI
- Signal Score
- 60.0/100
- Quality Compliance
- Assessment pending
- Headquarters
- Paris, France
- Modalities
- Small Molecule API, Microbial Fermentation API, Oligonucleotide, Peptide, HPAPI
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About EUROAPI
Auto-created by AI matchmaker. Data verification pending.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesSmall Molecule API, Microbial Fermentation API, Oligonucleotide, Peptide, HPAPI
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
60.0
Broad modality coverage (5 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Recent Press9 articles
Broad modality coverage (5 modalities)
Recent News 9 articles
EUROAPI: Full-Year 2022 Results - Business Wire
EUROAPI to Acquire BianoGMP for €10M - Contract Pharma
EuroAPI sheds UK facility as restructuring plan rolls on - Fierce Pharma
Euroapi Announces Restructuring Plan - DCAT Value Chain Insights
Euroapi, Sanofi’s Spinout CDMO Details Restructuring Plan, Including Mfg - DCAT Value Chain Insights
EUROAPI Enhances Its CDMO Capabilities Through a Pivotal Collaboration With SpiroChem, a Leading Contract Research Organization (CRO) - Business Wire
Sanofi’s Euroapi Launches as Stand-alone $1-Bn CDMO - DCAT Value Chain Insights
EuroAPI is ready to emerge from Sanofi’s shadow - Chemical & Engineering News
EuroAPI's troubles mount as audit reveals manufacturing lapses in Italy, spurring 2024 guidance suspension - Fierce Pharma
Frequently Asked Questions About EUROAPI
What is EUROAPI's CDMO Signal Score?
EUROAPI has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating EUROAPI for a manufacturing program?
Use the free AI matchmaker to compare EUROAPI against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Veranova
Devens, MA (US HQ); multiple global sites
Small Molecule API, HPAPI, ADC payload/linker, Oligonucleotide, Peptide
Fermion (Orion Group)
Espoo, Finland
Small Molecule API, HPAPI, Semi-solid drug product (creams, gels, ointments), Hormonal products
Sai Life Sciences
Hyderabad, India
Small Molecule API, Complex Small Molecules, HPAPI, ADC, Peptides, Oligonucleotides, Lipids / LNP, Intermediates, Drug Discovery (CRO)
Cambrex Corporation
East Rutherford, NJ
Small Molecule API, HPAPI, Controlled Substances, Oral Solid Dose, Solid State Research, Particle Engineering, Drug Product (OSD), Controlled Release
Ardena
Ghent, Belgium
Small Molecule API, Solid-State Research, HPAPI, PROTACs / Molecular Glues, Nanomedicine / LNP, Drug Product (Oral, Injectable, Semi-solid), CMC Regulatory, Bioanalysis